Key Takeaways
  • CHRD ($145.99): +4.2%, RVOL 1.0, at_demand
  • KEYS ($325.82): +1.2%, RVOL 0.9, between
  • RDVT ($72.00): +3.6%, RVOL 1.3, between
  • AVAV ($152.28): +3.7%, RVOL 1.1, between
  • RCAT ($9.28): +3.9%, RVOL 0.6, at_demand

Overview

Today’s session produced 21 continuation breakout signals, a healthy count that points to broad participation rather than an isolated pocket of strength. However, the SA Regime remains Cautious, with breadth sitting at a modest 52.6% above SMA-40 and sentiment only Bullish/Neutral. That combination tells us to favor quality over quantity — plenty of candidates are on the tape, but only a handful truly align with the leading sectors (Health Care, Communication Services, Energy) and show the RVOL/ATR%-M confirmation needed for high-conviction entries.

Quality Score: 3.5/5. Signal count and institutional depth (several names carry 1,000+ fund ownership) support the setup, but RVOL is underwhelming across most of the list — several top candidates print below 1.0x average volume, which tempers aggressiveness in a Cautious regime. Sector representation is genuinely diverse (Energy, Health Care, Software, Business Services, Aerospace, Electronics), so this is not a single-theme trade day; it’s a stock-picker’s environment where zone context and sector alignment separate the winners.

Top 5 Picks

CHRD ($145.99) — Energy / Oil&Gas-Explorers/Producers

Chord Energy sits in the top-ranked Energy sector (ATR% 1.9%) and is trading directly at_demand, just 1.28% above a well-defined 1h demand shelf. ATR%-M of 3.4 confirms expanding volatility in the direction of the move, and price is only 4.6% below its 52-week high — a leadership stock coiling for a fresh push. Institutional support is strong at 728 funds.

Entry Stop Target
$145.99 $143.50 $148.77

Institutional Backing: 728 funds, Bucket B0/B1/B2 — broad-based accumulation.

TARS ($71.92) — Health Care / Medical – Revenue Biotech

Tarsus Pharmaceuticals is a standout in the day’s top sector (Health Care, ATR% 3.1%). RVOL of 1.2 with ATR%-M of 3.1 shows real momentum behind the move, and the stock is at_demand with a tight 1h zone (1.69% distance). Supply overhead is razor-thin (0.09% away), meaning a clean push through $72.00 opens room quickly.

Entry Stop Target
$71.92 $70.20 $73.47

Institutional Backing: 396 funds, Bucket B0/B1.

FDS ($304.47) — Business Services / Comml Svcs-Market Rsrch

FactSet posts one of the strongest technical profiles today: RVOL 1.1, ATR%-M 4.3, and a clean at_demand setup 2.96% above a daily demand zone. Heavy institutional ownership (1,154 funds, INST bucket) adds conviction, and the supply zone is over 11% away, giving this breakout the widest runway of the group.

Entry Stop Target
$304.47 $289.00 $339.00

Institutional Backing: 1,154 funds, INST classification.

HUBS ($255.83) — Software / Comp Sftwr – Enterprise

HubSpot’s 7.9% move and ATR%-M of 3.1 make it the day’s biggest mover, backed by elite institutional ownership (1,411 funds, INST). The catch: price is already at_supply, just 1.67% from the daily resistance zone, so this is a momentum play rather than a fresh basing setup — best suited for aggressive traders willing to chase strength through resistance.

Entry Stop Target
$255.83 $238.00 $267.00

Institutional Backing: 1,411 funds, INST classification.

RDVT ($72.00) — Business Services / Comml Svcs-Outsourcing

Red Violet shows the best RVOL in the group at 1.3x with ATR%-M of 2.2, and sits just 3.0% below its 52-week high — a sign of persistent leadership. The demand zone is wider than ideal (12.49% away), so this is a momentum continuation rather than a tight zone entry; size accordingly.

Entry Stop Target
$72.00 $67.25 $76.00

Institutional Backing: 221 funds, Bucket B2.

Honorable Mentions

  • OBE ($11.81) — Energy name up 7.1% with strong ATR%-M 4.3, but already at_supply; watch for a pullback entry.
  • RCAT ($9.28) — At_demand in Software, but RVOL of 0.6 is too light for high conviction today.
  • VRSK ($191.02) — Elite institutional base (2,321 funds) but a razor-tight range between demand and supply limits reward.
  • AVAV ($152.28) — Aerospace/Defense name with negative ATR%-M (-0.7); momentum not confirmed yet.
  • KEYS ($325.82) — Strong institutional ownership (2,792 funds) but negative ATR%-M and sub-1.0 RVOL keep it on watch-only status.

Strategy Summary

Today’s continuation setups reward selectivity. The strongest risk/reward profiles — CHRD, TARS, and FDS — combine top-sector alignment (Energy and Health Care), tight demand-zone entries, and solid institutional sponsorship. HUBS and RDVT offer higher upside but require chasing momentum rather than buying a fresh base, appropriate only for traders comfortable with wider stops. With the SA Regime still Cautious, position sizing should stay disciplined and stops respected — this is a day for picking the cleanest technical stories, not casting a wide net.

Share: